Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension - Wikidata - awgldk - TriplyDB

Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension

Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension

http://www.wikidata.org/entity/Q24240794

about

Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension Lipid-lowering efficacy of atorvastatin Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension Blood pressure-lowering efficacy of loop diuretics for primary hypertension Lipid-lowering efficacy of rosuvastatin Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension Angiotensin receptor blockers for heart failure Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension Blood pressure lowering efficacy of alpha blockers for primary hypertension Time course for blood pressure lowering of angiotensin-converting-enzyme inhibitors Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension Exercise-based cardiac rehabilitation for coronary heart disease Spironolactone for hypertension Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study.Cost implications of improving blood pressure management among U.S. adults Intracluster correlation coefficients for sample size calculations related to cardiovascular disease prevention and management in primary care practices.Health promotion or pharmacological treatment for chronic diseases?A randomized trial of dietary sodium restriction in CKD Critical evaluation of the efficacy and tolerability of azilsartan.Defining metabolic syndrome and factors associated with metabolic syndrome in a poly-pharmaceutical population.Eplerenone for hypertension.Blood pressure-lowering efficacy of reserpine for primary hypertension.The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.Antioxidant and Angiotensin-Converting Enzyme Inhibitory Activity of Eucalyptus camaldulensis and Litsea glaucescens Infusions Fermented with Kombucha Consortium.Opportunities and limitations of genetic analysis of hypertensive rat strains.Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril.Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study.The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study.Specific Transcriptome Changes Associated with Blood Pressure Reduction in Hypertensive Patients After Relaxation Response Training.Exercise-based cardiac rehabilitation for patients with stable angina

P2860

Q24186037-B75FE5E6-ED2B-4C75-8EFB-ED540B085B16 Q24186048-65F644C2-0ED7-4921-90BD-2138F3C83137 Q24187301-DF85AE99-8203-4EF4-819E-25C2593B5BBF Q24187752-75C86D8C-ECD5-4B93-BD0B-A0F2CBA62A11 Q24187802-280B9E2F-36B1-4409-9AE5-1C924244E313 Q24187853-688965DB-8A8C-499E-8C51-04CB77744B15 Q24187891-489574D3-D165-4B54-BAE1-F770A9B922E5 Q24194304-3FD238F0-024E-4FC3-AEC1-3CDE77CBC8D2 Q24194532-F053163A-064A-4855-ACA4-48AF9EC491B9 Q24199125-668A2540-DEC3-4C11-9B58-73D469F5CFF2 Q24200205-2CAE3FAF-D98B-49B2-9FCC-6C90E4E08E82 Q24201322-684A47CD-791B-4410-A89A-9653CA4A12B6 Q24201753-47E9FC06-2015-4019-99F6-5801AD3318CD Q24202920-56A827FC-4E66-490F-BF69-208A042A335D Q24235365-4300F8E0-7FE8-4DA5-8A49-9ADE0444FE30 Q24236324-CE1A4AE6-2990-44DB-9170-A7F82D4AAAAA Q24240505-C44C2E78-9D8C-4545-AF6A-5BAC8DB65B17 Q24240561-340A8733-6DC4-4724-ADEA-3508FFA0ED41 Q34895375-FF0A3746-4643-4F6D-801A-F22CBEB4FE31 Q35190993-C0D78872-0759-4CA4-9735-761B8363F038 Q35204188-42986EE9-CF38-4AC4-BD79-2DF64233EE0A Q36478491-0405A0FF-0829-40B2-9C69-580F9C4B19F1 Q37340221-FCBD9AD6-ECD5-4BEB-88CE-9DBF97E86A28 Q38015816-B0EBD2C3-745C-4E5D-B275-320BC0541DD3 Q38828076-169CC4FA-1528-446A-AAAC-7F4559E1FEB6 Q38937259-CE931E93-129B-4583-89B1-AB894F664CAA Q39044699-AAB1857E-194A-49D9-86A7-103F9BF37ED3 Q39456476-0F9C0A70-520F-4322-99C0-A77749DD4C6F Q42354368-F045B7C7-F741-4393-972F-B360EFCD0335 Q42571400-1F46C619-8091-448A-AA73-4049A58299DE Q42935846-60EF54C5-C279-4B21-A69A-95A7B0002E31 Q51332447-D422072C-1E1D-44A5-9976-6B71A49B11ED Q51765491-72CC6759-6BEB-4450-AEE0-285FABED4CA1 Q52607911-2CF135F8-FB44-4EB7-9BFC-AAAF38D1119E Q57914770-1BB9B519-09A2-4103-BC55-E3B0618F8307

P2860

Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension

http://www.wikidata.org/entity/Q24240794

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Blood pressure lowering effica ...... itors for primary hypertension

@ast

Blood pressure lowering effica ...... itors for primary hypertension

@en

Blood pressure lowering effica ...... itors for primary hypertension

@en-gb

Blood pressure lowering effica ...... itors for primary hypertension

@nl

type

label

Blood pressure lowering effica ...... itors for primary hypertension

@ast

Blood pressure lowering effica ...... itors for primary hypertension

@en

Blood pressure lowering effica ...... itors for primary hypertension

@en-gb

Blood pressure lowering effica ...... itors for primary hypertension

@nl

prefLabel

Blood pressure lowering effica ...... itors for primary hypertension

@ast

Blood pressure lowering effica ...... itors for primary hypertension

@en

Blood pressure lowering effica ...... itors for primary hypertension

@en-gb

Blood pressure lowering effica ...... itors for primary hypertension

@nl

P1433

Q24240794-7698751C-EAB3-4566-B615-26BAB4649D89

P1476

Q24240794-B57D4C6D-708D-4C3E-B5CC-8E95193E5549

P2093

Q24240794-4AEC26B6-4064-459B-ABA2-374E68F86549

Q24240794-6916DE6D-F724-4ED3-9C1A-4B945114A5BC

Q24240794-6C1447E3-5FE9-4F89-B103-B42AB0DD40A8

Q24240794-B0F3F6EF-8870-4298-9839-3280E5C6401A

P2860

Q24240794-13906F35-73A9-4AED-91E3-23C1F06F44BE

Q24240794-19A31FBD-1EF5-48B2-963B-5442B0994955

Q24240794-1A9CA474-C9D3-4F80-8345-5A23B85BF1CC

Q24240794-1FAA433B-7FC1-4DBB-AC19-BEAD34770248

Q24240794-251D03E5-15B6-4045-993C-6D75E4E0AD70

Q24240794-282E65BD-54DF-4938-91DA-95B83F260433

Q24240794-2A194878-7E81-419D-A165-A27B04403DDA

Q24240794-2EE61873-35FC-4F66-9921-E7DF3477979F

Q24240794-2F6B304D-AF37-4F62-9822-389EE1F1B784

Q24240794-311740CF-ACEA-42A0-937C-F880AF21ACA2

P31

Q24240794-30F24D02-628B-4B39-8568-ECAC0F832ECE

Q24240794-5cd4c62a-dcd3-4635-b804-fd412c4df4c7

P356

Q24240794-159A6B39-66AB-4E21-86A3-5AFFE70D16A4

P577

Q24240794-AAA7BD6C-2898-420D-B2DC-81FF42D56850

P698

Q24240794-E3BF6E7C-16D4-4FA3-B013-21308EC3F2CC

P921

Q24240794-DFCA21BA-929D-48A3-BA5E-BB449D9B16CE

P356

14651858.CD003823.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Blood pressure lowering effica ...... itors for primary hypertension

@en

P2093

Balraj S Heran

http://www.w3.org/2001/XMLSchema#string

Inderjit K Heran

http://www.w3.org/2001/XMLSchema#string

James M Wright

http://www.w3.org/2001/XMLSchema#string

Michelle MY Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Dose finding studies with imidapril--a new ACE inhibitor.

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.

The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.

Lisinopril dose-response relationship in essential hypertension.

Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension

Effective dose range of enalapril in mild to moderate essential hypertension.

Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group

Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?

P31

scholarly article

P356

10.1002/14651858.CD003823.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18843651

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension